About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Transformative Pathology
›
top-articles
Transformative Pathology
25
(top 2%)
papers
1.1K
(top 2%)
citations
12
(top 2%)
h
-index
19
(top 2%)
g
-index
26
all documents
1.2K
doc citations
430
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program
Annals of Oncology
2018
246
2
Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenocarcinoma
JAMA Oncology
2017
221
3
An international study to increase concordance in Ki67 scoring
Modern Pathology
2015
195
4
Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration
Npj Breast Cancer
2016
109
5
A Framework for Biobank Sustainability
Biopreservation and Biobanking
2014
105
6
An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer
Modern Pathology
2019
78
7
Whole genomes define concordance of matched primary, xenograft, and organoid models of pancreas cancer
PLoS Computational Biology
2019
51
8
ISOWN: accurate somatic mutation identification in the absence of normal tissue controls
Genome Medicine
2017
44
9
Male breast cancer precursor lesions: analysis of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program
Modern Pathology
2017
32
10
Proximity ligation assays for isoform‐specific Akt activation in breast cancer identify activated Akt1 as a driver of progression
Journal of Pathology
2012
29
11
Abstract S6-05: Characterization of male breast cancer: First results of the EORTC10085/TBCRC/BIG/NABCG International Male BC Program
2015
20
12
Molecular characterisation of isogenic taxane resistant cell lines identify novel drivers of drug resistance
BMC Cancer
2014
16
13
A Practical Tool for Modeling Biospecimen User Fees
Biopreservation and Biobanking
2014
15
14
Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial
British Journal of Cancer
2013
6
15
A four gene signature predicts benefit from anthracyclines: evidence from the BR9601 and MA.5 clinical trials
Oncotarget
2015
6
16
Assessment of microtubule-associated protein (MAP)-Tau expression as a predictive and prognostic marker in TACT; a trial assessing substitution of sequential docetaxel for FEC as adjuvant chemotherapy for early breast cancer
Breast Cancer Research and Treatment
2014
5
17
Tumour infiltrating lymphocytes and stromal CD68 in early stage HER2 positive breast cancer
Journal of Clinical Pathology
2016
5
18
Expression of activated type I receptor tyrosine kinases in early breast cancer
Breast Cancer Research and Treatment
2012
3
19
Evaluation of applying IHC4 as a prognostic model in the translational study of Intergroup Exemestane Study (IES): PathIES
Breast Cancer Research and Treatment
2018
3
20
A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trial
Oncotarget
2016
2
21
Abstract P4-11-10: Time dependence of biomarkers: Non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancer
2015
1
22
Abstract P4-11-09: Comparison of immunohistochemical residual risk panels to predict risk in early breast cancers treated with endocrine therapy
2015
1
23
Abstract P4-11-03: Androgen receptor expression is an independent marker of lower residual risk in the TACT2 trial (CRUK/05/019)
2015
0
24
Abstract P4-11-04: Intrinsic subtypes and BCL2 as predictive and prognostic biomarkers in the TACT2 trial (CRUK/05/019)
2015
0
25
Abstract P3-07-08: Comparison of MammaTyper® RT-qPCR based subtyping with simulated breast cancer prognostic signatures
2020
0
site/software ©
exaly
; All materials licenced under
CC by-SA
.